For instance, Chen et al11 concluded that MSCs decrease the risk of colitis-related tumor formation secondary to different mechanisms, including reduced expression of pro-inflammatory factors, reduced inflammation at the bulk level, downregulation of STAT3 phosphorylation expression, and reduced tumor load and number. The gene discussed is STAT3; the disease is neoplasm.